fda compounding semaglutide update today 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like and tirzepatide, signaling a major shift in how these FDA says 'no clinical need'

Research over the last decade has shown that the gut microbiota helps shape L-cell biology and GLP-1 output not just through the food you eat, but through the metabolites your bacteria create as they digest it

Additionally, medical supervision ensures that weight loss occurs at a safe and sustainable rate, reducing the risk of muscle loss or nutritional deficiencies

Resistance to paclitaxel-based therapies is the primary reason this malignancy ranks as the leading cause of cancer-related mortality in men and the second highest cause in women (Park et al., 2016

Semaglutide is a GLP-1 receptor agonist that mimics your body's natural GLP-1 hormone

Add the upper arm to your rotation once you are comfortable with the injection process